Efficacy of Abciximab Bolus Only Regimen in Providing Inhibition of Platelet Action Over Time

NCT00929279 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

73

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome

Interventions

DRUG: bolus+infusion
DRUG: abciximab bolus only regimen

Sponsor

Università degli Studi di Ferrara